Neurocrine Biosciences to Participate at Investor Conferences in June

Rhea-AI Summary

Neurocrine Biosciences (Nasdaq: NBIX) will participate in two investor conferences in June 2024. The company’s top executives, including CEO Kevin Gorman, Chief Business Development and Strategy Officer Kyle Gano, and CFO Matt Abernethy, will present at the Jefferies Global Healthcare Conference on June 5 in New York and the Goldman Sachs 45th Annual Global Healthcare Conference on June 13 in Miami. These live presentations will be webcast and accessible on the company's website, with replays available shortly after the events.

Positive

• Neurocrine Biosciences' participation in high-profile investor conferences could attract investor interest.
• Presentations by top executives, including the CEO, signify the importance of these events.
• Availability of webcast and replay of presentations increases accessibility for investors.

Negative

• No new product launches or clinical trial updates were announced in the press release.
• Details on financial performance and specific business strategies were not provided.

Jefferies Global Healthcare Conference on June 5 in New York
Goldman Sachs 45^th Annual Global Healthcare Conference on June 13 in Miami

SAN DIEGO, May 29, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming investor conferences in June.

• Kevin Gorman, Chief Executive Officer, Kyle Gano, Chief Business Development and Strategy Officer, and Matt Abernethy, Chief Financial Officer will present at the Jefferies Global Healthcare Conference at 2:30 p.m. Eastern Time on Wednesday June 5, 2024 in New York.
• Kevin Gorman and Kyle Gano will present at the Goldman Sachs 45^th Annual Global Healthcare Conference at 10:40 a.m. Eastern Time on Thursday June 13, 2024 in Miami.

The live presentations will be webcast and may be accessed on Neurocrine Biosciences' website under Investors at www.neurocrine.com. A replay of the webcasts will be available on the website approximately one hour after the conclusion of the events and will be archived for approximately one month.

About Neurocrine Biosciences
Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine, and neuropsychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X (Formerly Twitter) and Facebook. (*in collaboration with AbbVie)

NEUROCRINE BIOSCIENCES, NEUROCRINE, and YOU DESERVE BRAVE SCIENCE are registered trademarks of Neurocrine Biosciences, Inc. The Neurocrine logo is a trademark of Neurocrine Biosciences, Inc.

View original content to download multimedia:https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-participate-at-investor-conferences-in-june-302157890.html

SOURCE Neurocrine Biosciences, Inc.

FAQ

When will Neurocrine Biosciences participate in the Jefferies Global Healthcare Conference?

Neurocrine Biosciences will participate in the Jefferies Global Healthcare Conference on June 5, 2024, in New York.

Who will present for Neurocrine Biosciences at the investor conferences in June 2024?

CEO Kevin Gorman, Chief Business Development and Strategy Officer Kyle Gano, and CFO Matt Abernethy will present at the investor conferences.

Where can I access the webcast of Neurocrine Biosciences' presentations in June 2024?

The webcasts of the presentations will be accessible on Neurocrine Biosciences' website under the Investors section.

What is the date for Neurocrine Biosciences' presentation at the Goldman Sachs 45th Annual Global Healthcare Conference?

Neurocrine Biosciences will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 13, 2024, in Miami.

Will the presentations at the investor conferences be available for replay?

Yes, replays of the webcasts will be available on Neurocrine Biosciences' website approximately one hour after the events and will be archived for about one month.